Avid Bioservices Inc (CDMO)

[keep_trying]

Rev M, is it imminent, you ask?

My view is that PPHM has been running a gauntlet that has suppressed "imminence" until PPHM established its work around mechanism through Avid sales and projections showing PPHM can self fund within the next year or so. Those that may want to see PPHM fail so their proprietary treatment sales can flourish need to deal with that. Weakness in Avid sales to Halozyme is giving an opportunity for Ronin to argue for Board control that would not likely have materialized as credible if Halozyme sales supported a $120 million annual sales outlook instead of $60 million. Value of PPHM intellectual property doesn't even need to weigh in, now that Avid is showing it is on the cusp of expanding sales volume. Cusp? Next year or so it now seems, whereas, before the revealing of delayed Avid sales leading into the last earnings call, PPHM was signalling self funding was coming together for their fiscal year 2018, which ends in April 2018.

Some market potential for PPHM tech mentioned on this board today seem high, but I haven't researched it.

Best wishes and IMO.

KT